Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY and JULIE MAK

Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Boston Scientific stock cleared that benchmark Wednesday, with a jump from 79 to 83 Wednesday.

As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.

This exclusive rating from Investor's Business Daily tracks market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price performance over the last 52 weeks holds up against all the other stocks in our database.

Decades of market research reveals that the market's biggest winners tend to have an 80 or better RS Rating in the early stages of their moves.

Looking For The Best Stocks To Buy And Watch? Start Here

Is Boston Scientific Stock A Buy?

Boston Scientific stock is working on a consolidation with a 46.38 buy point. See if it can break out in heavy trade. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips. Also, check out "Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks."

 

Top and bottom line growth moved higher in the company's most recent quarter. Earnings were up 96%, compared to 11% in the prior report. Revenue increased from 10% to 15%.

Boston Scientific stock earns the No. 4 rank among its peers in the Medical-Products industry group. Baxter International and Meridian Bioscience are also among the group's highest-rated stocks.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.